Office of Clinical Pharmacology Review (Aczone) - U.S. Food …

Apr 28, 2015 · OFFICE OF CLINICAL PHARMACOLOGY REVIEW ... 207154 Submission Date(s): 4/28/2015 Brand Name Aczone Gel, 7.5% Generic Name Dapsone ... Acne vulgaris is …

5%
OFF

Office Of Clinical Pharmacology Review (Aczone) - U.S. Food …

2 weeks from now

Apr 28, 2015 · OFFICE OF CLINICAL PHARMACOLOGY REVIEW ... 207154 Submission Date(s): 4/28/2015 Brand Name Aczone Gel, 7.5% Generic Name Dapsone ... Acne vulgaris is …

fda.gov

5%
OFF

Office Of Clinical Pharmacology Review - U.S. Food And Drug …

2 weeks from now

Office of Clinical Pharmacology Review NDA Number 207154 S-004 Link to EDR Application 207154 - Sequence 0054 - 0054 (234) 03/15/2019 ... Aczone® (dapsone) gel, 7.5% was …

fda.gov

5%
OFF

Clinical Review (ACZONE) - U.S. Food And Drug Administration

2 weeks from now

Clinical Review Patricia C. Brown, MD NDA 207154 ACZONE ® (dapsone) Gel, 7.5% 1 Recommendations/Risk Benefit Assessment 1.1 Recommendation on Regulatory Action

fda.gov

5%
OFF

CLINICAL REVIEW - U.S. Food And Drug Administration

2 weeks from now

Clinical Review Amy Sakulich Woitach, D.O., M.S. NDA 207154 S-004 Aczone (dapsone) gel, 7.5% CDER Clinical Review Template 7 Version date: September 6, 2017 for all NDAs and BLAs

fda.gov

5%
OFF

207154Orig1s000 - Food And Drug Administration

2 weeks from now

OFFICE OF CLINICAL PHARMACOLOGY REVIEW NDA: 207154 Submission Date(s): 4/28/2015 Brand Name Aczone Gel, 7.5% Generic Name Dapsone Primary Reviewer Doanh …

fda.gov

FAQs about Office of Clinical Pharmacology Review (Aczone) - U.S. Food … Coupon?

Does food affect pharmacokinetics of oral oncology drugs?

Keywords: clinical pharmacology; drug development; food-effect studies; oncology. © 2018, The American College of Clinical Pharmacology. Evaluation of the effect of food on the pharmacokinetics of oral oncology drugs is critical to drug development, as food can mitigate or exacerbate toxicities and alter systemic exposure. ...

What data was extracted from a clinical pharmacology review?

Data for recently approved small-molecule oncology drugs was extracted from the clinical pharmacology review in the sponsor's FDA submission package. Information on subject selection, meal types, timing of the study relative to the pivotal trial, and study outcomes was analyzed. ...

How many new drugs & biologics are available in 2023?

Our review findings for new drug applications (NDAs), NDA supplements, and biologics license applications (BLAs), including 351(k) applications (i.e., biosimilars), were integrated into benefit/risk assessments, ultimately bringing 55 safe and efective new drugs and biological products to patients in 2023 (See Table 1). Figure 3. ...

What is Clinical Pharmacology?

Clinical pharmacology is a multidisciplinary science, and our reviews synthesize information from all relevant clinical pharmacology knowledge areas including drug disposition, pharmacology and biomarkers, quantitative methods, drug safety, pharmacotherapy, and clinical trial methods. ...

What is Clinical Pharmacology corner?

Our Clinical Pharmacology Corner subscription service reaching over 95,000 stakeholders will deploy enhanced formats for disseminating information on notable updates and new drug approvals, and new free subscription services dedicated to quantitative and translational sciences are in the works. ...

How did OCP apply clinical pharmacology principles to drug development plans?

OCP applied clinical pharmacology principles to proposed drug development plans for INDs, engaging drug developers and experts in multiple formats (face-to-face meetings, written responses as requested, advisory committee meetings, etc.). ...